Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Keishi Fujio »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Keiko Yoshimoto < Keishi Fujio < Keishi Kubo  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000614 (2013) Mihoko Shibuya [Japon] ; Keishi Fujio ; Kaoru Morita ; Hiroaki Harada ; Hiroko Kanda ; Kazuhiko YamamotoSuccessful treatment with tocilizumab in a case of Cogan's syndrome complicated with aortitis.
000973 (2016) Toshihiko Komai [Japon] ; Hirofumi Shoda [Japon] ; Kenichi Yamaguchi [Japon] ; Keiichi Sakurai [Japon] ; Mihoko Shibuya [Japon] ; Kanae Kubo [Japon] ; Toshiyuki Takahashi [Japon] ; Keishi Fujio [Japon] ; Kazuhiko Yamamoto [Japon]Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report.
000A53 (2014) Saori Sakaue [Japon] ; Shuji Sumitomo [Japon] ; Kanae Kubo [Japon] ; Keishi Fujio [Japon] ; Kazuhiko Yamamoto [Japon]Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis.
001363 (2017) Yumi Tsuchida [Japon] ; Shuji Sumitomo [Japon] ; Hirofumi Shoda [Japon] ; Kanae Kubo [Japon] ; Keishi Fujio [Japon] ; Kazuhiko Yamamoto [Japon]Macrophage activation syndrome associated with tocilizumab treatment in adult-onset Still's disease.
001867 (2018) Tatsuya Atsumi [Japon] ; Keishi Fujio [Japon] ; Kunihiro Yamaoka [Japon] ; Minako Tomobe [Japon] ; Kazuyuki Kuroyanagi [Japon] ; Hideto Kameda [Japon]Safety and effectiveness of subcutaneous tocilizumab in patients with rheumatoid arthritis in a real-world clinical setting.
001B41 (2018) Yoshiya Tanaka [Japon] ; Hideto Kameda [Japon] ; Kazuyoshi Saito [Japon] ; Yuko Kaneko [Japon] ; Eiichi Tanaka [Japon] ; Shinsuke Yasuda [Japon] ; Naoto Tamura [Japon] ; Keishi Fujio [Japon] ; Takao Fujii [Japon] ; Toshihisa Kojima [Japon] ; Tatsuhiko Anzai [Japon] ; Chikuma Hamada [Japon] ; Yoshihisa Fujino [Japon] ; Shinya Matsuda [Japon] ; Hitoshi Kohsaka [Japon]Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naïve rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC study.
002756 (2020) Yoshiya Tanaka [Japon] ; Hideto Kameda [Japon] ; Kazuyoshi Saito [Japon] ; Yuko Kaneko [Japon] ; Eiichi Tanaka [Japon] ; Shinsuke Yasuda [Japon] ; Naoto Tamura [Japon] ; Keishi Fujio [Japon] ; Takao Fujii [Japon] ; Toshihisa Kojima [Japon] ; Tatsuhiko Anzai [Japon] ; Chikuma Hamada [Japon] ; Yoshihisa Fujino [Japon] ; Shinya Matsuda [Japon] ; Hitoshi Kohsaka [Japon]Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Keishi Fujio" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Keishi Fujio" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Keishi Fujio
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021